Advies - vergoed selumetinib (Koselugo®) voor de behandeling van goedaardige tumoren bij kinderen met neurofibromatose type 1 (NF1)
Cited by Zorginstituut Nederland on
Zorginstituut Nederland (Netherlands Healthcare Institute) is an independent Dutch administrative body that ensures that Dutch citizens are and remain insured in accordance with the Health Insurance Act and the Long-Term Care Act. The Healthcare Institute occupies an independent position between the Ministry of Health, Welfare and Sport, health insurers, care providers and patient organizations.